Cargando…

Sex-dependent immune response and lethality of COVID-19

COVID-19 has spread to all countries around the world after it was first discovered in Wuhan of China at the end of 2019. It is caused by a novel coronavirus called SARS-CoV-2 with much semblance to SARS-CoV including the sequence homology and disease symptoms. It is reported to be more infectious t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Albert Jiarui, Li, Xiajun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837330/
https://www.ncbi.nlm.nih.gov/pubmed/33352531
http://dx.doi.org/10.1016/j.scr.2020.102116
_version_ 1783642937236652032
author Li, Albert Jiarui
Li, Xiajun
author_facet Li, Albert Jiarui
Li, Xiajun
author_sort Li, Albert Jiarui
collection PubMed
description COVID-19 has spread to all countries around the world after it was first discovered in Wuhan of China at the end of 2019. It is caused by a novel coronavirus called SARS-CoV-2 with much semblance to SARS-CoV including the sequence homology and disease symptoms. It is reported to be more infectious than SARS-CoV due to higher binding affinities between its spike protein and the ACE2 receptor on cell surface. Despite this, its case fatality rate is much lower compared with that of SARS-CoV although it varies in different countries. However, the case fatality rate increases steadily with age and it is reported to be the highest in aged COVID-19 male patients in almost all countries. Consistent with these, females have higher antiviral immune responses. Males and females are different in inflammatory response and aberrantly hyperactive cytokines are the main lethal causes of COVID-19. Interestingly, the gene encoding the ACE2 receptor protein and some genes encoding the immune regulatory proteins such as TLR7 are located on X chromosome which is subject to X chromosome inactivation and sex hormone regulation. These may account for some sex-dependent immune responses and lethality observed in COVID-19 patients. In general, children are less likely to be infected with SARS-CoV-2 and only less than 1% of pediatric COVID-19 patients may die of COVID-19. However, the most severe pediatric cases become multisystem inflammatory syndrome that is similar to Kawasiki disease with features of viral infection. Since most infected kids were boys in China, there may be sex-dependent immune response in pediatric COVID-19 cases as well.
format Online
Article
Text
id pubmed-7837330
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-78373302021-01-27 Sex-dependent immune response and lethality of COVID-19 Li, Albert Jiarui Li, Xiajun Stem Cell Res Article COVID-19 has spread to all countries around the world after it was first discovered in Wuhan of China at the end of 2019. It is caused by a novel coronavirus called SARS-CoV-2 with much semblance to SARS-CoV including the sequence homology and disease symptoms. It is reported to be more infectious than SARS-CoV due to higher binding affinities between its spike protein and the ACE2 receptor on cell surface. Despite this, its case fatality rate is much lower compared with that of SARS-CoV although it varies in different countries. However, the case fatality rate increases steadily with age and it is reported to be the highest in aged COVID-19 male patients in almost all countries. Consistent with these, females have higher antiviral immune responses. Males and females are different in inflammatory response and aberrantly hyperactive cytokines are the main lethal causes of COVID-19. Interestingly, the gene encoding the ACE2 receptor protein and some genes encoding the immune regulatory proteins such as TLR7 are located on X chromosome which is subject to X chromosome inactivation and sex hormone regulation. These may account for some sex-dependent immune responses and lethality observed in COVID-19 patients. In general, children are less likely to be infected with SARS-CoV-2 and only less than 1% of pediatric COVID-19 patients may die of COVID-19. However, the most severe pediatric cases become multisystem inflammatory syndrome that is similar to Kawasiki disease with features of viral infection. Since most infected kids were boys in China, there may be sex-dependent immune response in pediatric COVID-19 cases as well. The Author(s). Published by Elsevier B.V. 2021-01 2020-12-16 /pmc/articles/PMC7837330/ /pubmed/33352531 http://dx.doi.org/10.1016/j.scr.2020.102116 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Li, Albert Jiarui
Li, Xiajun
Sex-dependent immune response and lethality of COVID-19
title Sex-dependent immune response and lethality of COVID-19
title_full Sex-dependent immune response and lethality of COVID-19
title_fullStr Sex-dependent immune response and lethality of COVID-19
title_full_unstemmed Sex-dependent immune response and lethality of COVID-19
title_short Sex-dependent immune response and lethality of COVID-19
title_sort sex-dependent immune response and lethality of covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837330/
https://www.ncbi.nlm.nih.gov/pubmed/33352531
http://dx.doi.org/10.1016/j.scr.2020.102116
work_keys_str_mv AT lialbertjiarui sexdependentimmuneresponseandlethalityofcovid19
AT lixiajun sexdependentimmuneresponseandlethalityofcovid19